Please turn JavaScript on

ONC

Want to know the latest news and articles posted on ONC?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: Oncologynewscentral.com

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.66 / day

Message History

Bispecific antibodies are improving survival and reshaping frontline and relapsed/refractory DLBCL treatment options. Here’s a roundup of the latest key developments.

Read full story
Rucaparib (Rubraca) improved PFS by 19.4 months in patients with homologous recombination deficient (HRD) advanced ovarian cancer, but the benefit was smaller among patients without HRD.

Read full story
Oncologists who participated in *ONC*’s fourth annual Drug Report revealed shifting prescribing patterns, big practice challenges, and evolving opinions on the FDA.

Read full story
Thank you for joining our Community Insights discussion on Perioperative Management of Early NSCLC. We value your feedback—please complete this short survey to share your thoughts about the program and help us improve future events.

Read full story
The maker of tazemetostat (Tazverik) withdrew the drug from all markets amid concerns about secondary malignancy risks outweighing benefits.

Read full story